The use of neuropsychological tests across Europe: the need for a consensus in the use of assessment tools for dementia
- PMID: 20597968
- DOI: 10.1111/j.1468-1331.2010.03134.x
The use of neuropsychological tests across Europe: the need for a consensus in the use of assessment tools for dementia
Abstract
Background and purpose: The centres dedicated to dementia throughout Europe use different neuropsychological tests in clinical practice. The European Federation of Neurological Societies task force on neuropsychological tests produced this survey on neuropsychological tests currently being used in different European countries to gather knowledge on the practice of dementia centres and to promote the harmonization of such instruments and future multicentre collaborations.
Methods: National representatives of 34 countries received a questionnaire and 25 (73.5%) sent it back.
Results: A few instruments, Mini-Mental State Examination (MMSE), Trail Making Test (TMT), Verbal Fluency and Clock Drawing Test, were available in all countries. Wechsler Adult Intelligence Scales and MMSE were reported to be valid, respectively, in 20 (80%) and 19 (76%) countries, whereas Verbal Fluency and Stroop Test are valid in 18 (72%) of them. Of the 25 countries, 17 have validation norms for Clock Drawing Test and TMT (68%), and Neuropsychiatric Inventory, Alzheimer's Disease Assessment Scale - Cognitive Subscale, Rey Complex Figure Test, Digit Symbol and Beck Depression Inventory were standardized in 16 countries (64%). The remaining tests were validated, at most, in about half of them. Not all countries certificate neuropsychology.
Conclusions: Despite the substantial differences in the tools used by the EFNS countries for most domains surveyed by the questionnaire, there is at least one neuropsychological instrument used by about 80% of the countries. There is clearly the need for a broader consensus in the use of neuropsychological tests for dementia diagnosis.
© 2010 The Author(s). European Journal of Neurology © 2010 EFNS.
References
-
- Olesen J, Leonardi M. The burden of brain diseases in Europe. Eur J Neurol 2003; 10: 471-477.
-
- Andlin-Sobocki P, Jonsson B, Wittchen H-U, Olesen J. Cost of disorders of the brain in Europe. Eur J Dementia 2005; 12(Suppl. 1): 1-27.
-
- Lobo A, Launer LJ, Fratiglioni L, et al. Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic diseases in the elderly research group. Neurology 2000; 54(Suppl. 1): S4-S9.
-
- Waldemar G, Phungh KT, Burns A, et al. Access to diagnostic evaluation and treatment for dementia in Europe. Int J Geriatr Psychiatry 2006; 22: 47-54.
-
- Waldemar G, Dubois B, Emre M, Scheltens P, Tariska P, Rossor M. Diagnosis and management of Alzheimer’s disease and related disorders: the role of neurologists in Europe. Eur J Neurol 2000; 7: 133-144.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
